Pulmatrix: Eva Jack named chief business officer
Article continues below
Ms. Jack most recently served as Managing Director at MedImmune Ventures, the corporate venture fund of MedImmune, LLC, which included serving as a board member or board observer for several portfolio companies.
Ms. Jack initially joined MedImmune’s business development group serving as Director and Associate Director, completing numerous in-licensing and out-licensing transactions.
Prior to her tenure at MedImmune, Ms. Jack held various senior leadership positions at Intel Corporation, including Senior Manager of Strategic Investments. ■